Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-09-14 | 2022-09-02 |
| Drug Identification Number | 02264315 | 02264315 |
| Brand name | HEPARIN SODIUM INJECTION, USP | HEPARIN SODIUM INJECTION, USP |
| Common or Proper name | HEPARIN SODIUM INJECTION, USP | HEPARIN SODIUM INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | HEPARIN SODIUM | HEPARIN SODIUM |
| Strength(s) | 1000UNIT | 1000UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1 mL | 1 mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-09-01 | 2022-09-01 |
| Estimated end date | 2022-09-15 | 2022-09-15 |
| Actual end date | 2022-09-13 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be facing a supply interruption on our Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 1 mL and Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 30 mL effective September 1, 2022 until September 15, 2022. | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be facing a supply interruption on our Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 1 mL and Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 30 mL effective September 1, 2022 until September 15, 2022. |
| Health Canada comments |